CONNECT WITH US
HealthTech

HealthTech

Apple, OpenEvidence launch conversational health AI study and app

Healthcare Dive logo

Published on

Add as a preferred source on Google
Apple, OpenEvidence launch conversational health AI study and app

The tech juggernaut and clinical AI company will research what drives consumer trust and the quality of health AI responses, among other areas.

Apple’s new study is open to up to 200,000 eligible participants age 21 and older across the U.S., per a press release. It will be conducted through an app, where users can ask questions about their health and explore medical information. Participants will also have the option to share their personal data, such as resting heart rate, activity, sleep or lab results, to personalize their interactions.

The study was designed by Apple, but uses AI developed by OpenEvidence, Desai said during Apple’s session on HLTH’s main stage. OpenEvidence offers an AI-powered medical search tool that’s used by almost two-thirds of U.S. physicians, the company told NBC News earlier this year.

“We’re studying what builds user trust, how people comprehend responses, the quality of responses, and we wanted to work with a clinically grounded partner, and that is OpenEvidence,” Desai said.

Healthcare products powered by large language models often give incomplete or confusing answers. Apple is hoping that the research can inform how to present complex information in a clearer way, the company said. The app could also help consumers prepare for visits with their doctors.

OpenEvidence CEO Daniel Nadler, who joined Desai onstage, said that patients’ interactions with physicians are so short — frequently just 10 or 15 minutes — that conversations might fall through the cracks. The new app could help communicate users’ health data and questions to bridge that divide, Nadler said.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.